The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Just checked on the London Stock Exchange site and it shows 2 late reported deals last night for £9000 and £8700 (both for 150000 shares) that did not show up on LSE - haven't seen that size trade in a while. After all this time there are still only 138m shares in circulation which is remarkable - currently 6.18 to buy, 6.04 to sell
I'm currently being offered 6.03p for my shares ....not the 5.7p as shown on LSE. £1m placing was done in March '21 at 7.5p and the loan of £3.2m from Polo (plus the extra £300k if GCM elect to take it) can be converted to shares at the same price. A few buys are now coming through and judging by ****stan, China, USA, etc then coal is going to be a significant energy resource for a few years to come yet. GCM's resource would be transformational for Bangladesh.......
Earl lost whatever credibility he had left last week when he tried to encourage PI's to invest in TRP saying its licence is next to Shell's promising Graff-1 drill, offshore Namibia...........when it is actually over 1000km away..........!!
Please stop replying on EarlofAims thread....it just gives credence to his misinformation
All TRP and GBP investors - Please do some research as to the locations of the license block Shell is currently drilling compared to where both TRP and GBP have their licenses .....you will find they are a long way away......
Great fan of the potential of this share…… but shouldn’t Art have disclosed the new info on the prospect rather than sitting on it since Aug 21 (from memory of his podcast)?
Torreagus: It is not at least 12m of oil.
The RNS states: 'an approximate 12 metre gross oil column was encountered. Wireline logging results will be used to determine the reservoir properties (porosity, net to gross) and to confirm a net oil column.'
The net oil column will be less than 12m.......
https://www.hellenicshippingnews.com/viridis-bulk-carriers-granted-public-funding-to-build-ammonia-powered-vessels/
Relevant to us?
Full ask up to £500....nothing available over
…… and there’s a huge difference between saying the patient died WITH omicron compared to the patient died BECAUSE OF omicron…… and all the reports I’ve seen so far say the former …….. hmmmm
Do a dummy sell……. Barx is quoting 5.85…..
They’ll buy your shares at 5.85……. looks like they want them
A great update statement from CPX's Chairman last week. In case anybody missed it some excerpts follow:
- Despite being in a 4 month lockdown, Q1 sales have again been strong - up 25% on same period last year
- New factory in Sydney now operational
- Sales order book remains strong and the Company remains on track to meet market expectations
- Demand for thin prismatic supercapacitors from IoT markets is growing.
- In addition to the sales orders already we have received, we are seeing strong enquiry levels for supercapacitors for IoT sensors, drones, microgrids and metering.
- Operationally we are actively looking to add more technicians to accelerate the pace of improvement and product development at Seven Hills
- Production from our contract manufacturer, Nationgate, is now recovering strongly, as Malaysia also comes out of COVID lock down. Nationgate has been adding staff to its CAP-XX production line which has increased output by over 25%.
- We have installed a new enterprise resource planning system which has gone live and is designed to enable CAP-XX to cater for significant growth. We expect to see further benefits from this going forward.
- On the licencing and litigation front we are waiting for the Delaware Court ordered mediation with Maxwell Technologies.
- Cash reserves remain strong at A$2.7m with no debt and our R&D tax rebate of A$3.2m is expected in the next two months. The cash burn rate continues to decrease.
All this in a Company who's share price has declined from 14p to 5p in the space of 10 months in a sector which is expected to experience significant growth worldwide over the next few years.
Can't buy a bean.........in anticipation of a good update tonight maybe
Can't buy anything at all on Barcs..........looking very strong
Directors already own 33% of the Company..........and the new CEO, and other Directors, have options at £1 a share............!
Moving quickly............
...and forgot to mention that the new CEO has options over 2m shares .......at £1.00 per share......!
Commercialisation of cancer vulnerability test due to start Q4 2021..........completed move to far larger premises at end of Sept 21......share price driven down..........Directors and ex-Directors hold 33%.........other significant shareholders total 35%...........only 94m shares in issue.....these will be hard to get hold of once the upward move starts.
As new CEO, Jon Burrows, stated in their recent RNS: Dr Jon Burrows, CEO of Oxford BioDynamics, said: "With OBD's strong growth outlook, our move to this larger, purpose-built facility is key to the execution of our strategy. It is important in particular as we prepare for commercialization of EpiSwitch® CiRT - our Checkpoint Inhibitor Response Test for cancer - in Q4, and with respect to our recent FNIH PACT award [3]. These are linked to the immune-oncology interests of the pharma industry, which has generated significant attention, and we expect more activity from these groups.
Larus ...... any apology then?